Time between milestone events in the Alzheimer's disease amyloid cascade
•The time-from-Aβ pathology measure identifies early signs of disease progression.•Increases in tau pathology and cognitive dysfunction occur 4–8 years prior to Aβ-positivity.•Slowing the spread of tau pathology and cognitive decline may require treatment prior to significant Aβ pathology. Estimate...
Saved in:
Published in: | NeuroImage (Orlando, Fla.) Vol. 227; p. 117676 |
---|---|
Main Authors: | , , , , |
Format: | Journal Article |
Language: | English |
Published: |
United States
Elsevier Inc
15-02-2021
Elsevier Limited Elsevier |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | •The time-from-Aβ pathology measure identifies early signs of disease progression.•Increases in tau pathology and cognitive dysfunction occur 4–8 years prior to Aβ-positivity.•Slowing the spread of tau pathology and cognitive decline may require treatment prior to significant Aβ pathology.
Estimate the time-course of the spread of key pathological markers and the onset of cognitive dysfunction in Alzheimer's disease.
In a cohort of 335 older adults, ranging in cognitive functioning, we estimated the time of initial changes of Aβ, tau, and decreases in cognition with respect to the time of Aβ-positivity.
Small effect sizes of change in CSF Aβ42 and regional Aβ PET were estimated to occur several decades before Aβ-positivity. Increases in CSF tau occurred 7–8 years before Aβ-positivity. Temporoparietal tau PET showed increases 4–5 years before Aβ-positivity. Subtle cognitive dysfunction was observed 4–6 years before Aβ-positivity.
Increases in tau and cognitive dysfunction occur years before commonly used thresholds for Aβ-positivity. Explicit estimates of the time for these events provide a clearer picture of the time-course of the amyloid cascade and identify potential windows for specific treatments. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 1053-8119 1095-9572 |
DOI: | 10.1016/j.neuroimage.2020.117676 |